Next step
Premium unlocks GO/NO-GO, pipeline tracking, consortium building, and the AI Proposal Assistant.
Evaluate → Track → Team → Prepare → Submit
Premium intelligence
Unlock AI evaluation, advanced insights, and programme analytics for this call with a Premium plan.
AI evaluation and GO/NO-GO
Fit score, submission probability, effort estimate, and personalized GO/NO-GO recommendations.
Advanced AI insights
Personal fit narrative, competitive landscape, bid requirements preview, and eligibility analysis.
Historical programme analytics
Overlapping funded projects and programme evidence for this call.
26 Jul 2026, 10:15
Portal ID
FT:50140523
Summary
Description
Expected Outcome
Scope
References
[1] See definition of FAIR data in the introduction to this Work Programme part.
[2] For pharmacological interventions: phase 1 and/or phase 2 clinical trials.
[3] Applicants may address any mono- or combinatorial pharmacological and/or non-pharmacological interventions.
[4] Other diseases are not within the scope of this topic.
[5] Comparative effectiveness studies are not within the scope of this topic.
[6] The use of the term 'racial or ethnic origin' does not imply an…
Eligible
Funding distribution
Budget totale: €63,800,000
≈ 8 progetti finanziabili
Additional links
Opportunity matching and partner suggestions is a Premium feature
Ranked consortium partners and ecosystem fit for this call require a completed recommendation profile and Premium.
Start free • Cancel anytime • 14-day refund guarantee
Topics
Keywords
Continue your journey
GO or REVIEW? Assemble partners, explore complementary finance, or compare related calls before opening the AI Proposal Assistant.
Find organisations that fit this call.
No direct matches yet — use the browse link.
Open Partner FinderDebt, equity, or guarantees that often pair with this funding.
Related opportunities — continue without starting from zero.
